You are herePharma News

Pharma News

Sagent Pharma Notify the Launch of Vancomycin Hydrochloride for Injection

Sagent Pharmaceuticals, Inc., a specialty pharmaceutical company has launched Vancomycin hydrochloride for injection, USP, an anti-infective, in a 10 gram preservative-free pharmacy bulk package presentation.

Exelixis’ cabozantinib received Fast Track designation by US FDA for RCC treatment

The US Food & Drug Administration (FDA) has granted Fast Track designation to Exelixis, Inc's cabozantinib for treatment of patients with advanced renal cell carcinoma (RCC). Cabozantinib is the Exelixis' lead compound . Exelixis, Inc. is a biopharmaceutical company committed to developing small molecule therapies for the treatment of cancer.

Dr. Reddy’s Laboratories and its subsidiary filed three NDAs for psoriasis, rosacea and migraine

Dr. Reddy's Laboratories and its subsidiary, Promius Pharma™, LLC announced the filing of three 505(b)(2) New Drug Applications (NDAs) with the U.S. Food and Drug Administration (US FDA).

India examines WTO option over EU drug suspension order

India is examining whether to take up with World Trade Organisation (WTO) the European Union's (EU) suspension order for sale of about 700 generic drugs which were approved based on clinical trials by pharma major GVK Biosciences.

Pharma sector to soon showcase new drugs: Vardhan

The Indian pharmaceutical sector would soon be showcasing new drugs for malaria, osteoporosis and diabetes, Union Minister for Science and Technology Harsh Vardhan said. These drugs are currently undergoing clinical trials, he said.


Sun Pharma, Israel university ink pact to develop anti-cancer drugs

Sun Pharmaceutical Industries has inked a pact with Israel's Technion university to develop anti-cancer drugs. The subsidiaries of the Mumbai-based drug firm and Technion - Israel Institute of Technology have entered into an exclusive worldwide research and license agreement, Sun Pharma said in a statement.

Gum disease treatment is linked with preventing Heart Disease

A new study from the Forsyth Institute is helping to shed more light on the important connection between the mouth and heart. According to research recently published online by the American Heart Association, scientists at Forsyth and Boston University have demonstrated that using an oral topical remedy to reduce inflammation associated with periodontitis, more commonly known as gum disease, also results in the prevention of vascular inflammation and can lower the risk of heart attack.

Genetically modified Salmonella may treat Cancer

Genetically modified Salmonella can kill cancer cells, suggests new research published in mBio, an American Society for Microbiology. one particular strain of salmonella found to be most effective at killing cancer cells and shrinking tumors, and also not toxic.

US FDA approved Aurobindo anesthesia supplement drug product

Aurobindo Pharma has received the final approval from the US Food and Drug Administration to manufacture and market Atracurium Besylate injection in single and multi-dose vials in the US market.

US FDA approved indication for Ethicon’s EVARREST Fibrin Sealant Patch

Ethicon, a part of J&J, received expanded FDA indication for its EVARREST Fibrin Sealant Patch to be used to help control bleeding during adult liver surgeries. The device is bioabsorbable and contains human thrombin and fibinogen proteins that participate in clot formation. It retains its strength and stickiness while it’s still around. EVARREST is a novel convergence of biologics and medical device that rapidly and reliably stops problematic bleeding during surgery on the first attempt in indicated patients. EVARREST is a fibrin sealant patch indicated for use with manual compression as an adjunct to hemostasis . The unmatched mechanism of action behind EVARREST drives rapid and durable clot formation. The technology is comprised of a flexible composite patch, which contains embedded human biologics (human thrombin and fibrinogen), which are proteins involved in the natural clotting process.